These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 9846420)

  • 41. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
    Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
    Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
    Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
    Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
    J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada.
    Hemming AW; Cattral MS; Greig PD; Meisner J; Turcotte L; Lilly LB; Levy GA
    Clin Transplant; 1998 Oct; 12(5):425-9. PubMed ID: 9787952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
    Kyllönen LE; Salmela KT
    Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
    Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
    Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients.
    Parquet N; Reigneau O; Humbert H; Guignard M; Ribaud P; Socié G; Devergie A; Espérou H; Gluckman E
    Bone Marrow Transplant; 2000 May; 25(9):965-8. PubMed ID: 10800064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the pharmacokinetics of cyclosporine in patients following long-term administration after a kidney transplant: comparison of Neoral and Sandimmune.
    Takahara S; Ichimaru N; Kojima Y; Namba Y; Toki K; Shi Y; Yoshimura K; Matsumiya K; Nonomura N; Okuyama A
    Transplant Proc; 2004 Mar; 36(2 Suppl):456S-460S. PubMed ID: 15041387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
    Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
    Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
    Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
    J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J
    Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A; Steel L; Sharples L; Stewart S; Parameshwar J; McNeil K; Wallwork J
    Ther Drug Monit; 1999 Feb; 21(1):17-26. PubMed ID: 10051050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Dahlke LJ; Wilson SM; Steers JL; Krom RA
    Transplantation; 1997 Sep; 64(5):726-31. PubMed ID: 9311710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoral therapy in liver transplantation.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2225-8. PubMed ID: 8769206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.